Want to continue the discussion? Send me a message.

“I feel amazing” is usually what we hope to hear after months of depression. With bipolar depression, it can also be the moment we need to slow down and get much more precise about what “better” actually means.

We start Part 1 of our Bipolar Depression in Practice series with a deceptively hard clinical question: how do we tell the difference between recovery toward euthymia and a slide into hypomania or mania? I walk through a case that changed how I listen, especially when a client knows the language of mental health but does not recognize elevated mood in their own life. From there, we get practical and specific, because broad questions often miss the signal.

We dig into the assessment details that matter most: energy that returns to baseline versus energy that overshoots, productivity that fits a normal range versus productivity that feels endless, and spending changes that only make sense when you know the client’s usual pattern. Sleep gets its own deep dive, because “I slept four hours” can describe insomnia with exhaustion or decreased need for sleep with sustained function, and those are not the same clinical story. We also talk about why “baseline” is personal, how long depression can reset a client’s reference point, and how collateral input from family or partners can add context without automatically defining the client’s reality.

Want to continue the discussion? Send me a message.

We wait for a relapse, a missed stretch of pills, or a hospitalization, and only then the words “long-acting injectable” finally show up. I’m stepping back to ask a cleaner question for bipolar I disorder care: what needs to be true before an LAI earns a place in the conversation, not as a last resort, but as a thoughtfully explained option in maintenance treatment.

I walk through the difference between mentioning LAIs, considering them, and recommending them, because those are not the same moment clinically. We talk about why I introduce the option when a patient is stable and thriving on an oral medication, how psychoeducation reduces pressure, and why I don’t want anyone learning about injections for the first time during a crisis. From there, we get into a hard truth about mania: insight can drop while symptoms rise, and what feels “normal” internally can look dangerous externally. That distinction matters for relapse prevention planning and shared decision-making.

I also share what sticks with me after episodes end: patients may be clinically better but still recouping their lives, relationships, work, and public digital footprints. Finally, I unpack a case that exposes a common misunderstanding, when a patient assumes the injection replaces the rest of the treatment plan and quietly stops a key medication.

Want to continue the discussion? Send me a message.

A patient says, “I hate needles,” and the room tightens. Do we hear a hard no, a fear we can work with, or a past experience that needs words before it needs a plan? We get real about long-acting injectable antipsychotics (LAIs) and what the conversation actually sounds like in everyday psychiatric care when I’m excited about an option and my client is unsure.

We dig into motivational interviewing skills that matter in the moment: reflective listening, strategic silence, and affirmations that don’t feel like pressure. I walk through “elicit, provide, elicit” in plain language so we can share why an LAI might help (daily adherence struggles, breakthrough symptoms, clearer monitoring) and then give the decision right back to the person in front of us. We also name the uncomfortable truth that clinician comfort and uncertainty can shape how we present choices, sometimes making an injection sound like a last resort even when it isn’t.

“I need to think about it” gets treated with respect and structure, including what to do when clients Google medications, land on Reddit horror stories, or worry about side effects and long duration in the body. We talk about building a realistic follow-up plan, keeping the door open without standing in the doorway, and what changes when an LAI already has a history from hospitalization. By the end, success isn’t a yes to the injection, it’s clarity: do we understand the concern, the meaning, and what happens next?

Want to continue the discussion? Send me a message.

A long-acting injectable antipsychotic can do more than solve “Did you take your meds?” It can change the entire way we interpret progress, setbacks, and what “medication failure” actually means. I’m starting a three-part series on LAIs in real practice because I’ve watched injectables open doors for clients who were stuck in cycles of relapse, hospitalization, and constant daily decision fatigue.

We talk about the part that rarely gets addressed head-on: many people’s first experience with an injection is an emergency shot in an inpatient unit. That history can make LAI conversations feel loaded before they even start. From there, I share how inconsistent oral dosing can quietly distort our clinical conclusions, and why I try to ask medication questions in a way that gets honest information instead of yes or no answers.

You’ll also hear why I track improvement beyond one loud symptom like hearing voices, and how small functional shifts can signal that treatment is starting to work even when the headline symptom lingers. Then we get into the harder scenario: what it means when someone relapses even while getting their injection on time, and how sleep loss, grief, stress, and environment can change the picture without automatically indicting the medication. If you prescribe or take antipsychotic medication for schizophrenia, schizoaffective disorder, or bipolar disorder, this is a practical, story-driven guide to using LAIs thoughtfully with real-world nuance.

Podcast, Newsletter & More

https://linktr.ee/Dr.LoriKumarDNP

Want to continue the discussion? Send me a message.

A new psychiatric medication gets approved, social media starts buzzing, and suddenly the question lands in the exam room: “Should I take this?” We want to slow that moment down. A headline about a new mechanism of action is interesting, but it does not answer the real clinical question: where does this treatment fit for the person sitting right in front of us, with their diagnosis, goals, risks, and real life constraints.

We walk through a practical, evidence-based way to evaluate new medications for schizophrenia and bipolar disorder, starting with the FDA label. What is it actually approved to treat? Which age group? Is it meant to be used alone or with other meds? From there, we zoom into clinical trials and talk honestly about how controlled study settings differ from community mental health and routine outpatient care where adherence varies, stressors happen, insurance changes, and follow-up is less frequent.

We also dig into communication, because many clients now research medications on Google, Reddit, and personal blogs before we finish the visit. We share how to respect that curiosity while clarifying the difference between personal stories and clinical evidence, how to interpret long side-effect lists with real context, and why the teach-back method can make a plan safer and easier to follow. Finally, we focus on tolerability over time and what “success” truly means, not just on a rating scale but in sleep, connection, functioning, and quality of life as defined by the client.

Podcast, Newsletter & More

https://linktr.ee/Dr.LoriKumarDNP

Want to continue the discussion? Send me a message.

Psychosis can be terrifying, urgent, and unmistakable and it can still be misdiagnosed if we treat a symptom like a final answer. We walk through a clinical truth with huge consequences for assessment and documentation: psychosis is a symptom, not a diagnosis. When “schizophrenia” shows up in the chart too early, it can steer future clinicians, shape family expectations, and even change how a patient understands themselves long before the evidence is solid.

We use the case of a 27-year-old woman brought to the ER after little sleep, paranoid beliefs, and a warning voice to ask a harder question: when psychosis is present, what do we actually know, and what still requires time? We define delusions, hallucinations, disorganized thinking, disorganized behavior, and catatonia in plain language, then widen the differential diagnosis beyond schizophrenia to include bipolar disorder, major depression with psychotic features, substance-induced psychosis, medication effects, sleep deprivation, trauma, grief, sensory impairment, and medical causes such as delirium.

To make this practical, we lay out four overlapping timelines you can build in real clinical settings: the psychosis timeline, the mood timeline, the exposure timeline, and the medical and cognitive timeline. We also talk about the pressure for a discharge diagnosis and an insurance code, why “provisional” can be the most clinically honest choice, and how to document uncertainty as an active plan. Finally, we share phrases that validate distress without agreeing with delusions, plus shared decision making tips when antipsychotic medication concerns like weight gain, sedation, and akathisia affect adherence.

Podcast, Newsletter & More

https://linktr.ee/Dr.LoriKumarDNP

Want to continue the discussion? Send me a message.

Hi I am your host Dr. Lori Kumar. I am a doctoral-prepared, board-certified psychiatric mental health nurse practitioner.

Schizophrenia and bipolar disorder get talked about constantly, yet many patients and families walk away feeling more confused and more alone. We made this show to slow the conversation down and rebuild it with clarity, nuance, and respect. I share why person-centered psychiatric care requires more than diagnostic criteria and prescriptions, and how different settings change what we prioritize from acute safety and stabilization to long-term outpatient trust, rural access barriers, geriatric complexity, and forensic considerations. I will name the real questions people bring to the room: What does this diagnosis mean? Why now? What should we expect? How do medications work? What if the first plan fails?

I unpack why schizophrenia is more than hallucinations and delusions and why bipolar disorder is more than mood swings, including how episodes affect sleep, energy, judgment, thinking, relationships, and safety. You’ll hear how clinicians approach differential diagnosis, why timeline and context matter, and how trauma, substance use, sleep deprivation, medical conditions, and medications can mimic or complicate symptoms. I close with a practical framework for treatment planning: antipsychotics, mood stabilizers, monitoring, side effects, long-acting injectables, and the non-medication supports that strengthen recovery like psychotherapy, family education, routines, sleep stabilization, and social connection.

If you want thoughtful, evidence-based conversations that translate psychiatric language into something patients can use, you've come to the right place! Let's start unpacking.

Podcast, Newsletter & More

https://linktr.ee/Dr.LoriKumarDNP